Latest News about RCUS

Recent news which mentions RCUS

< Previous 1 2 3 4 Next >

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

May 26, 2023

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday

May 26, 2023

Nasdaq Rises 1%; US Goods Trade Gap Widens In April

May 26, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session

May 26, 2023

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

May 26, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

May 26, 2023

3 Analyst Upgrades That Smart Investors Won’t Ignore

May 17, 2023

Earnings Preview For Arcus Biosciences

May 08, 2023

Arcus Biosciences Earnings Perspective: Return On Capital Employed

March 06, 2023

Earnings Scheduled For February 28, 2023

February 28, 2023

Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data

December 20, 2022

Dow Jumps 150 Points; Crude Oil Rises 1%

December 20, 2022

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

December 20, 2022

Where Arcus Biosciences Stands With Analysts

December 20, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

December 20, 2022

Nasdaq Edges Lower; Gold Rises 1.5%

December 20, 2022

Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday

December 20, 2022

US Stocks Edge Higher; Dow Rises 50 Points

December 20, 2022

Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients

December 20, 2022

Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures

November 28, 2022

Expert Ratings for Arcus Biosciences

November 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022

November 18, 2022

ON Semiconductor, Global Payments And Other Big Losers From Monday

November 01, 2022

Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations

October 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022

October 11, 2022

Citi reduces Arcus Biosciences (RCUS) PT to $40. RCUS is currently trading at $25.45.

August 18, 2022

Arcus Biosciences Return On Capital Employed Insights

August 12, 2022

Analyst Ratings for Arcus Biosciences

August 04, 2022

Recap: Arcus Biosciences Q2 Earnings

August 03, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.